IRadimed Corporation
IRMD | NASDAQ
$85.15
+$2.69 (+3.26%)
Sep 22, 2026, 2:42 PM ET · Market open
Company Profile
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Key Executives
| Name | Position |
|---|---|
| Roger E. Susi | Founder, Chairman, Chief Executive Officer & President |
| John F. Glenn | Chief Financial Officer & Corporate Secretary |
| Chris Williamson | Executive Vice President of Continuous Improvement & Information Technology |
| Jeff Chiprin | Chief Commercial Officer |
| Lynn Neuhardt | Vice President of Research & Development |
| Matt Garner | Controller |
| Randy Waddell | Vice President of Worldwide Sales & Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 18, 2026 | 8-K/A | [Amend] Current Report |
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 31, 2026 | 8-K | Current Report |
| Jul 28, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jun 24, 2026 | 8-K | Current Report |
| Jun 23, 2026 | 4 | Filing |
| Jun 04, 2026 | 4 | Filing |
| Jun 02, 2026 | 4 | Filing |
| May 28, 2026 | 4 | Filing |
| May 20, 2026 | 4 | Filing |
IRadimed Corporation
| Country | United States |
| IPO Date | Jul 15, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 166 |
| CEO | Roger E. Susi |
Contact Details
1025 Willa Springs Drive Orlando,
Florida 32826 United States
Stock Details
| Ticker Symbol | IRMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001325618 |
| CUSIP Number | 46266A109 |
| ISIN Number | US46266A1097 |
| SIC Code | 3841 |
Recent News
- 6 days ago / defenseworld.netHead-To-Head Contrast: iRadimed (NASDAQ:IRMD) & Medline (NASDAQ:MDLN)
- 18 days ago / gurufocus.comiRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
- 2 months ago / marketbeat.comiRadimed Q2 Earnings Call Highlights
- 2 months ago / seekingalpha.comIRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
- 2 months ago / globenewswire.comIRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
- 2 months ago / globenewswire.comIRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
- 4 months ago / fool.comIRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
- 5 months ago / gurufocus.comiRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Tells Investors
- 5 months ago / seekingalpha.comIRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
- 5 months ago / zacks.comiRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
Add to Watchlist
Select watchlists to add or remove IRMD